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1. INTRODUCTION 
1. 1 INTRODUCTION 
 Analytical methods development and validation play important roles in the 
discovery, development, and manufacture of pharmaceuticals. The current good 
manufacturing practice (CGMP) and Food Drug Administration (FDA) Guidelines 
insist for adoption of sound methods of analysis with greater sensitivity and 
reproducibility. Development of a method of analysis is usually based  on prior art 
(or) existing literature, using the same (or) quite similar instrumentation .It is rare 
today that an HPLC-based method is developed that does not in same way relate (or) 
compare to existing, literature based approaches. Today HPLC (High performance 
liquid chromatography) is the method of choice used by the pharmaceutical industry 
to assay the intact drug and degradation products. The appropriate selection and 
chromatographic conditions ensure that the HPLC method will have the desired 
specificity. UV spectroscopy is also a simple analytical tool widely used for routine 
assay of drugs. Hence for the assay of the selected drugs HPLC and UV 
spectroscopy has been chosen for these proposed methods. 
The developed chromatographic methods further validated as per ICH or 
USFDA guidelines for all the critical parameters. To access the precision and to 
evaluate the results of analysis the analyst must use statistical methods. These 
methods include confidence limit, regression analysis to establish calibration curves. 
In each analysis the critical response parameters must be optimized and recognized 
if possible. 
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Pharmaceutical Analysis plays a major role today, and it can be considered 
as an interdisciplinary subject. Pharmaceutical analysis derives its principles from 
various branches like chemistry, physics. And microbiology etc. pharmaceutical 
Analytical techniques are applied mainly in two areas, quantitative analysis and 
qualitative analysis, although there are several other applications. 
Drugs and pharmaceuticals are chemicals or like substances, which or of 
organic inorganic or other origin. Whatever may be the origin, we some property of 
the medicinal agent to measure them quantitatively or qualitatively. 
In recent years, several analytical techniques have been evolved that 
combined two or more methods into one called “hyphenated” technique eg: GC/MS, 
LC/MS etc. The complete Analysis of a substance consists of four main steps. 
The concept of analytical chemistry lies in the simple, precise and accurate 
measurements. These determinations require highly sophisticated instruments and 
methods like mass spectroscopy, gas chromatography, HPTLC, HPLC, etc. HPLC 
method is sensitive, accurate, precise and desirable for routine estimation of drugs in 
formulations.  
Thereby it is advantageous than volumetric methods. Many HPLC methods 
has been developed and validated for the quantitative determination of various 
marketed drugs. 
  Analytical method development and validation places an important role in 
drug discovery and manufacture of pharmaceuticals. These methods are used to 
ensure the identity, purity, potency and performance of drug products majority of 
analytical development effort goes into validating a stability indicating method. So it 
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is a quantitative analytical method based on the structure and chemical properties of 
each active ingredient of the drug formulation. 
Most of the drugs can be analyzed by HPLC method because of several 
advantages like rapidity, specificity, accuracy, precision, reproducibility, ease of 
automation and eliminates tedious extraction and isolation procedures. 
On the literature survey, it was found that most of the analytical method 
available for the above mentioned drug is applicable for quantification in plasma 
samples, the most widely used method being liquid chromatography-mass 
chromatography. So it is felt that there is a need to develop accurate, precise 
analytical methods for the estimation of the drug in solid dosage formulation. 
Newer analytical methods are developed for these drugs or drug combinations 
of the below reasons: 
• There may not be suitable method for a particular analyte in the specific matrix. 
• Existing method may be too error prone or unreliable (have poor accuracy 
and precision). 
• Existing method may be expensive, time consuming, energy intensive and 
may not be provide sensitive or analyte selectivity, and not easy for 
automation. 
• Newer instrumentation and techniques may have evolved that provide 
opportunities for improved methods. 
• There may be need for an alternate method to confirm, for legal and 
scientific reasons. 
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The newly developed analytical methods having their importance in different 
fields that include, research and development centre (R&D), Quality control 
department (QC). Approved testing laboratories, chemical Analysis laboratories etc. 
For analysis of these drugs different analytical methods are routinely being used. 
The analytical methods are classified as classical and instrumental. These 
methods signal measured in those methods was mentioned in following table. 
Table 1: Classification of analytical method 
Measurement signal Analytical method 
Chromatographic techniques 
Electrical Gas chromatography (Thermal conductivity 
detector) 
Increase in electrical current Gas chromatography (Flame ionization detector) 
Decrease in electrical current Gas chromatography (Flame capture detector) 
Electromagnetic radiation 
absorbed 
Liquid chromatography (Ultraviolet Light detector, 
Diode array detector) 
Electrical Ion  chromatography 
Spectrophotometric method 
Emission radiation 
 
 
Emission spectroscopy (X-ray, UV, Visible), 
Fluorescence and phosphorescence (X-ray, UV, 
Visible), radiochemistry. 
Absorption of radiation Spectrophotometry (X-ray, UV, Visible, IR)NMR  
and Electron spin resonance spectroscopy. 
Scattering of radiation Turbidimetry, Nephelometry, Raman spectroscopy 
Refraction of radiation Refractometry, Interferometry 
Diffraction of Light X-ray and Electron diffraction 
Rotation of radiation Polarimetry, Optical rotatory dispersion 
Mass to charge ratio Mass spectroscopy 
Electro chemical techniques 
Electrical potential Potentiometry 
Electrical current Polarography, Amperometry 
Electrical resistance Conductometry 
Miscellaneous techniques 
Rate of reaction Kinetic method 
Thermal properties DTA and DSC 
Classical methods 
Mass Gravimetric Analysis 
Volume Volumetric Analysis 
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1.2 CHROMATOGRAPHY 
Techniques related to chromatography have been used for centuries to 
separate materials such as dyes extracted from plants. Russian botanist Tswett is 
credited with the discovery of chromatography. In 1903 he succeeded in separating 
leaf pigments using a solid polar stationary phase, It was not until 1930s that this 
technique was followed by Kuhn and Leder as well as Reichstein and van Euw for 
the separation of natural products. Martin and synge were awarded the Nobile prize 
for their work in 1941 in which they described liquid-liquid chromatography. Martin 
and synge applied the concept of theoretical plates as a measure of chromatographic 
efficiency. The term “chromatography” (Color-Writing derived from the Greek for 
Color-chroma and Write-Graphing). 
CHROMATOGRAPHY IN THE PHARMACEUTICAL WORLD 
In the modern pharmaceutical industry, chromatography is the major and 
integral analytical    tool applied in all stages of drug discovery, development, and 
production. The development of new chemical entities (NCEs) is comprised of two 
major activities. Drug discovery and development. The goal of the drug discovered 
is to investigate a plethora of compounds employing fast screening approaches, 
leading to generation of lead compounds and then narrowing the selection through 
targeted synthesis and selective screening (lead optimization). The main functions of 
drug development are to completely characterize candidate compounds by 
performing drug metabolism, preclinical and clinical screening, and clinical trails. 
Throughout this drug  discovery and development paradigm, rugged analytical 
HPLC separation methods are developed, at each phase of development to analyses 
of a myriad of samples are performed to adequately control and monitor the quality 
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of the prospective drug candidates, excipients, and final products. Effective and fast 
method development is of paramount importance throughout. This drug 
development life cycle. This requires a thorough understanding of HPLC principles 
and theory which have solid foundation for appreciating the many variables that are 
optimized during fast and effective HPLC method development and optimization. 
1.3. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
1.3.1Brief Historical prospective of chromatography: 
The historical development of liquid chromatography has been extensively 
reviewed and can be traced as far back as they early 1900, where the Russian botanist 
Zwett used a variant of liquid chromatography to separate some colored plant 
substances. 
The focus was on modern development in HPLC, a term that was coined in 
late 1960s with the advent of more sophisticated instrumentation, better engineered 
separation columns, and reliable and highly efficient stationary phases and 
packaging materials. 
These technological advances have been, In part, fuelled, by the need to 
separate an increasingly large variety of differing compounds classes encountered as 
API s, e.g. Antibiotic, sulphonamides  nucleosides, fat soluble vitamins neutral and 
non polar compounds. Additional challenges include developing faster and more 
consistent HPLC methods requiring higher flow rates, while maintaining peak shape, 
peak symmetry and efficiencies. Another important analytical challenge is the desire 
to detect and accurately quantify low levels of impurities at level present in API 
materials. 
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High-pressure liquid chromatography quickly improved with the 
development of column packing materials. Additional convenience of on-line 
detectors became rapidly a powerful separation technique and is today called as 
High-performance liquid chromatography (HPLC) 
 One of the early problems with liquid state chromatography was the slow rate at 
which analysis took place. Early methods use gravity feed, and it was not 
uncommon diffusion and soon. 
 This problem was largely overcome by the advent High-performance liquid 
Chromatography (HPLC). In this system the pressure is applied to the column 
forcing the mobile phase through at much higher rate. 
 For an analysis to take several days to complete. This led not only to great delay 
but also the excessive time on the column and thus inevitably led to loss of 
resolution by 
Table: 2. Different types of chromatographic techniques 
S.NO Basic principle involved Type of chromatography 
1 Techniques  by 
Chromatographic bed shape 
 
Column chromatography 
Paper chromatography 
Thin layer chromatography 
2 Techniques by physical state 
of mobile phase 
Gas chromatography 
Liquid chromatography 
3 Affinity chromatography Super critical fluid chromatography 
4 Techniques by separation 
mechanism 
Ion Exchange chromatography 
Size Exclusion chromatography 
5 Special techniques Reversed phase chromatography 
Two-dimensional chromatography 
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HPLC 
In High-performance liquid chromatography, mobile as well as the stationary 
phase compete for the distribution of the sample components. In case of HPLC, 
separation is based on adsorption and partition. Adsorption chromatography 
employs high-surface area particles that adsorb the solute molecules. Usually a polar 
solid such as silica gel, alumina or porous glass beads and a non-polar mobile phase 
such as heptanes, octane or chloroform are used in adsorption chromatography. 
In partition chromatography, the solid support is coated with a liquid 
stationary phase. The relative distribution of solutes between the two liquid phases 
determines the separation. The stationary phase can either polar or non-polar. If the 
stationary phase is non-polar, it is called normal phase partition chromatography. If 
the opposite case holds, it is called reversed-phase partition chromatography. In 
normal phase mode, the polar molecule partition preferentially in to the stationary 
phase and are retained longer than non-polar compounds. In reverse phase partition 
chromatography, the opposite behavior is observed. 
1.3.2TYPES OF HPLC TECHNIQUES: 
Based on modes of chromatography: 
• Normal phase chromatography 
• Reverse phase chromatography 
Based on principle of separation: 
• Adsorption chromatography 
• Ion exchange chromatography 
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• Size exclusion chromatography 
• Affinity chromatography 
Based on elution technique: 
• Isocratic separation 
• Gradient separation 
Based on the scale of operation: 
• Analytical HPLC 
• Preparative HPLC 
Ion Exchange chromatography: Due to differences in the affinity of ions for the in 
exchange.  
Size Exclusion chromatography: Due to differences in molecular weight and size 
of the molecules to be separated. 
Affinity chromatography: Separation is based on a chemical interaction specific to 
the target species. The more popular revered phase mode uses a buffer and an added 
counter-ion of opposite charge to the sample with separation being influenced by 
pH, ionic strength, temperature, concentration of and type of organic co-solvents(s). 
Chairal chromatography: Separation of the enantiomers can be achieved on 
chairal stationary phases by the formation of diastereomers. 
Analytical HPLC: only analysis of the samples is done. Recovery of the samples                     
for reusing is normally not done. 
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1.3.3 MOST COMMONLY USED METHODS IN HPLC 
Normal phase chromatography: 
For a polar stationary bed like silica we need to choose a relatively non-polar 
Mobile phase. This mode of operation is termed as Normal phase chromatography. 
Here the least polar component elutes first, and increasing the mobile phase polarity 
leads to decrease in elution time. Non-polar solvents like pentane, Hexane, 
isooctane, cyclohexane, etc. are more popular. It is mainly used for separation of 
nonionic, non-polar to medium polar substances. 
Reverse phase chromatography: 
In 1960s, chromatographers started modifying the polar nature of the silanol 
group by chemically reacting silicon with organic silanes. The object was to make 
silica less polar or non-polar so that polar solvents can be used to separate water-
soluble polar compounds. Since the ionic nature of the reverted, the 
chromatographic separation carried out with such silica is referred to as Reverse- 
phase chromatography.  Here the most post components elutes first. Increasing 
mobile phase polarity leads to decrease In elution time. Common solvents used in 
this mode include Methanol /Acetonitrile /Isopropanol etc. Mostly used for 
separation of ionic and polar substances. The parameters that govern the retention in 
reversed phase system are the following: 
a. The chemical nature of the stationary phase surface. 
b. The type of solvents that compose the mobile phase. 
c. pH and ionic strength of the mobile phase. 
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Isocratic elution:  A separation in which the mobile phase composition remains 
constant throughout the procedure is termed isocratic (meaning constant 
composition). 
Gradient elution: The mobile phase composition does not have to remain constant. 
A separation in which the mobile phase composition is changed during the 
separation process is described as a gradient elution. 
1.3.4 INSTRUMENTATION OF HPLC: 
The mobile phase components HPLC instrument and their working functions are 
described below. 
• Mobile phase and reservoir 
• Solvent degassing system 
• Pump 
• Injector 
• Colum 
• Detector 
• Data system 
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Figure1: Schematic diagram of HPLC instrumentation 
I.MOBILE PHASE AND RESERVIOR: 
 The most common type of solvent reservoir is a glass bottle. The mobile 
phase is pumped under pressure from one of several reservoirs and flows through 
the column at a constant rate. With micro particulate packing, there is a high-
pressure drop across a chromatography column. Mobile phase used for HPLC are 
typically mixtures of organic solvents and water or aqueous buffers. The following 
points should also be considered when choosing a mobile phase: 
• The essential to establish that the drug is stable in the mobile phase for at least 
the duration of the analysis. 
• Excessive salt concentrations should be avoided. High salt concentrations can 
result in precipitation, which can damage HPLC equipment. 
• The mobile phase should have a pH 2.5 and Ph 7.0 to maximize the lifetime of 
the column. 
• Reduce cost and toxicity of the mobile phase by using methanol instead of 
acetonitrile when possible minimizes the absorbance of buffer. 
• Use volatile mobile phase when possible, to facilitate collection of products and 
LC-MS analysis. Volatile mobile phases include ammonium acetate, ammonium 
phosphate, formic acid, and trifluoroacetic acid. Some caution is needed as these 
buffers absorb below 220nm. 
Mobile phase used for HPLC are typically mixtures of organic solvents and water or 
aqueous Buffers. Physical properties of some HPLC solvents were summarized in  
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Table: 3.Physical properties of common HPLC solvents 
Solvent MW BP 
 
RI 
(25OC) 
 
UV 
λ Cut-
off(nm) 
Density 
g/ml(25Oc) 
Viscosity 
CP(25OC) 
Dielectric 
Constant 
Acetonitrile 41.0 82 1.342 190 0.787 0.358 38.8 
Dioxane 88.1 101 1.420 215 1.034 1.26 2.21 
Ethanol 46.1 78 1.359 205 0.789 1.19 24.5 
Ethyl 
Acetate 
88.1 77 1.372 256 0.901 0.450 6.02 
Methanol 32.0 65 1.326 205 0.792 0.584 32.7 
CH2CI2 84.9 40 1.424 233 1.326 0.44 8.93 
Isopropanol 60.1 82 1.375 205 0.785 2.39 19.9 
n-propanol 60.1 97 1.383 205 0.804 2.20 20.3 
THF 72.1 66 1.404 210 0.889 0.51 7.58 
a  :The wavelength at which the absorbance of 1cm is 1.0 
 
II. SOLVENT DEGASSING SYSTEM: 
            The constituents of the mobile phase should be degassed and filtered before 
use. Several methods are employed to remove the dissolved gases in the mobile 
phase. They include heating and stirring, vacuum degassing with an aspirator, 
filtration through 0.45µfilters, vacuum degassing with an air-soluble membrane, 
helium purging ultra signification or purging or combination of these methods. 
HPLC systems are also provided an online degassing system, which continuously 
removes the dissolved gases from the mobile phase. 
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III. PUMP: 
High pressure pumps are needed to force solvents through packed stationary 
phase beds. Smaller bed particles require higher pressures. There are many 
advantages to using smaller particles, but they may not be essential for all 
separations. 
 The degree of flow of control also varies with pump expense. More 
expensive pumps include such state of the art technology as electronic feedback and 
multithreaded configurations. It is desirable to have an integrated degassing system, 
either helium purging, or membrane filtering. 
IV. INJECTOR: 
Sample introduction can be accomplished in various ways. The simplest 
method. Is touse an injection value in more sophisticated LC systems, automatic 
sampling devices are incorporated where the sample is introduced with the help of 
auto samplers and microprocessors in liquid chromatography, liquid samples may be 
injected directly and solid samples need only be dissolved in an appropriate solvent. 
Sample introduction techniques can be used with a syringe an injection valve. 
V.  COLUMN: 
The heart of the system in the column. Many different reverse phase columns 
will provide excellent specificity for any particular separation. It is therefore best to 
routinely attempt separations with a standard C8 or C18 column and determine if it 
provides good separations. Reverse phase columns differ by the carbon chain length, 
degree of end capping and percent carbon loading. Diol, cyano and amino groups 
Chapter 1 Introduction 
Dept of Pharmaceutical Analysis 15 J.K.K.Nattraja College of Pharmacy 
can also be used for reverse phase chromatography. Typical HPLC columns are 5, 
10, 15, and 25cm in length and are filled with small diameter (3, 5 or 10µm) 
particles. The internal diameter of the columns is usually 4.6mm; this is considered 
the best compromise for sample capacity, mobile phase consumption, speed and 
resolution. However, if pure substances are to be collected (preparative scale), then 
larger diameter columns may be needed. 
VI. DETECTOR: 
The detection of UV light absorbance offers both convenience and sensitivity 
for molecules. When a chromophore is present, the wavelength of detection for a 
drug should be based on its UV spectrum in the mobile phase and not in pure 
solvents. The most selective wavelength for detecting a drug is frequently the 
longest wavelength maximum to avoid interference from solvents, Buffers and 
Excipient. Other method of detection can be useful are required in some instances. 
1. Solute specific detectors (UV-Vis, Fluorescence, Electrochemical, Infra-red, 
Radio activity) 
2. Bulk property detectors (Refractive index, Viscometer, conductivity) 
3. Desolvation detector (Flame ionization etc) 
4. LC-MS detectors 
5. Reaction detectors 
VII. DATA SYSTEM: 
Since the detector signal is electronic, using modern data collection 
techniques can aid the signal analysis. In addition, some systems can store data in a 
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form for highly sophisticated computer analysis at a later time. The main goal in 
using electronic data systems is to increase analysis accuracy and precision, while 
reducing operator attention. 
PERFORMANCE CALCULATIONS: 
Calculating the following values (which can be included in a custom report) 
used to access overall system performance. 
           1. Relative retention 
           2. Theoretical plates 
           3. Capacity factor 
           4. Resolution 
           5. Peak asymmetry 
           6. Plates per meter 
The following information furnishes the parameters used to calculate these 
system performance values for the separation of two chromatographic components. 
(Note: where the terms w and t both appear in the same equation they must be 
expressed the same units) 
System suitability parameters: 
The theory of chromatography has been used as the basis for system-
suitability tests, which are set of quantitative criteria that test the suitability of the 
chromatographic system to identify and quantify drug related samples by HPLC at 
any step of the pharmaceutical analysis. 
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1. Relative retention: The time elapsed between the injection of the sample 
components in to the column and their detection is known as the retention time (Rt).                                         
α = (t2-ta) / (t1-ta) 
Where, 
α =Relative retention 
t1= Retention time of the one peak measured from point of injection. 
t2 = Retention time of the second peak measured from point of injection. 
ta = Retention time of an inert peak not retained by the column, measured from point 
of injection. 
2. Theoretical plates: 
n =16 (t R / w) 2 
Where, 
n =Theoretical plates 
tR = Retention time of the component 
W = width of the base of the component peak using tangent method. 
3. Capacity factor: The capacity factor describes the thermodynamic basis of the 
separation and its definition is the ratio of the amounts of the solute at the stationary 
and mobile phases within the analyte band inside the chromatographic column. 
K1 = (t2/t a)-1 
Where, 
K1 = Capacity factor 
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ta = Retention time of an inert peak not retained by the column, measured from point 
of injection. 
4. Resolution: the gap between two peaks 
R =2 (t2- t1) / (w2-w1) 
Where, 
R =Resolution between a peak of interest (peak 2) and the peak preceding it (peak 1) 
W2 = Width of the base of component peak 2 
W1 = Width of the base of component peak 1 
5. Peak asymmetry 
T =W0.05/ 2f 
Where, 
T = Peak asymmetry, or tailing factor. 
W0.05 = Distance from the leading edge to the tailing edge of the peak, measured at a 
point 5 % of the peak height from the baseline. 
f= Distance from the peak maximum to the leading edge of the peak. 
6. PLATE PER METER: 
N =n/L 
Where, 
N = plates per meter. 
L = column length in meters. 
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Advantages:  
• HPLC separations can be accomplished in a minutes, in some cases even in 
seconds. 
• High resolution of complex sample mixture into individual components. 
• Rapid growth of HPLC is also because of its ability to analyse substances that 
are unsuitable for Gas Liquid chromatographic (GLC) analysis due to non-
volatility or thermal-instability. 
• Quantitative analyses are easily and accurately performed and errors of less than 
1 % are common to most HPLC methods. 
• Depending on sample type and detector used, it is frequently possible to measure 
10-9 g or 1 ng of sample. With special detectors, analysis down to 10-12 pg has 
been reported. 
• As HPLC is versatile, it can be applied to wide variety of samples like organic, 
inorganic, high molecular weight liquids, solids and ionic-nonionic compounds. 
Disadvantages: 
• HPLC instrumentation is expensive and represents a major investment for many 
laboratories. 
• HPLC cannot handle gas samples. 
• HPLC is poor identifier. It provides superior resolution but it does not provide 
the   information that identifies each peak. 
• Only one sample can be analysed at a time. 
Finally, at present there is no universal and sensitive detector. 
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1.4 ANALYTICAL METHOD DEVELOPMENT 
Methods are developed for new products when no official methods are 
available. Alternate methods for existing (non-pharmacopoeial) products are 
developed to reduce the cost and time for better precision and ruggedness. Trail runs 
are conducted, method is optimized and validated.  
When alternate method proposed is intended to replace the existing 
procedure, comparative laboratory data includes merits /demerits should be made 
available.The important factors, which to be taken into account to obtain reliable 
quantitative analysis, are 
     1. Careful sample and sample preparation 
     2. Appropriate choice of the column 
     3. Selection flow rate 
     4. Selection of detector wavelength 
     5. Selection of column temperature 
Documentation starts at the very beginning of the development process. A 
system for full documentation of development studies must be established. Analyte 
standard characterization. 
a) All known information about the analyte and its structure is collected i.e., 
physical and chemical properties. 
b) The literature for all type of information related to the analyte is surveyed. 
c) Using the information in the literatures and prints, methodology is adapted. The 
methods are modified where ever necessary. 
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d) The required instrumentation is setup. Installation, operational and performance 
qualification of instrumentation using laboratory SOP,s are verified. 
HPLC method development is based on few basic steps which include: 
1.Information on sample, define separation Goals 
                                                                    ↓ 
2. Need special HPLC procedure, sample   pre-treatment, etc? 
                                                                     ↓ 
3.Choose detector and detector setting 
                                                                     ↓ 
4.Choose LC method; preliminary run, estimate best separation 
                                                                      ↓ 
5.Optimize separation conditions 
                                                                      ↓ 
6.Check for problems or requirement for special procedures 
                                                                      ↓ 
                                                                       ↓ 
8.Validate method for release to routine laboratory 
 
Figure2. Steps in HPLC method development 
Method goals: 
 Analytical method goals are often defined as method acceptance criteria for 
peak resolution, precision, specificity, sensitivity. For instance, pharmaceutical 
methods for potency assays of an API typically require the following: 
• Minimal sample work-up (extra and inject if possible 
• Robust method that doesn’t require extensive execution. 
• Low cost per analysis. 
7a.Recover purified material 
 
7b.Quantitative  
calibration 
 
 
7c  Qualitative method  
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Table 4: Separation goals in HPLC method development 
Goals Comment 
Resolution Precise and rugged quantitative analysis requires that Rs be 
greater than 1.5. 
%RSD Precision of retention time and peak area, <1-2%RSD. 
Range Linearity in the range of 50-150% of the lab label claim. 
Analysis time 5-30min ( 60min for complex samples) 
Separation time <5-10min is desirable for routine procedures. 
Quantification ≤2 %( %RSD) for assays, ≤5% for less demanding analyses, 
≤15% for trace analyses. 
Pressure <150 bar is desirable, <200bar is usually essential(new 
column assumed) 
Peak height Narrow peaks are desirable for large signal/ noise ratios 
 
Sample analyte information: 
The information is useful for the selection of appropriate sample preparation 
procedures as well as the initial detection and chromatographic modes. If data not 
available (e.g., Pka solubility), separate studies should be initiated as soon as 
possible. The sample related information is summarized in Table4. 
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Table 5: Sample and analyte information 
Sample/analyte Information 
Sample 
 
Number of components 
concentration range of analytes 
Analyte (s) 
 
 
 
Chemical structure, molecular weight and functional groups 
Pka 
Solubility 
Chromophore, wavelength (max) 
Chairal centers, isomers 
Spectral data (MS,NMR, IR, and UV) 
Stability and toxicity 
Others Purity of reference standard materials 
 
1. Careful sampling and sample preparation: 
Before beginning method development, it is need review what is known 
about the sample in to define the goals of separation. The sample related information 
that is important to summarized in  
Table: The chemical composition of the sample can be providing valuable clues for 
the best choice of initial conditions for an HPLC separation. 
 Number of compounds present 
 Molecular weight of compounds  
 Pka values of compounds 
 UV spectra of compounds 
 Concentration range of compounds in samples of interest 
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2. Separation goals 
The goals of HPLC separation need to be specified clearly, which include 
• The use of HPLC to isolate purified sample components for spectral 
identification Or quantitative analysis 
• It may necessary to separate all degradants or impurities from a product for 
reliable content assay or not 
• In quantitative analysis, the required levels of accuracy and precision should be 
known 
• Whether a single HPLC procedure is sufficient for raw materials or one or more 
different  procedures are desired for formulations    
• When the number of samples for analysis at one time is greater than 10, a run 
time of less than 20 minutes often will be important. Knowledge on the desired 
HPLC equipment. 
• HPLC equipment, HPLC experience and academic training do to operators have 
3. Sample preparation: samples come in various forms 
• Solutions ready for injection 
• solutions that require dilution, buffering, addition of an internal                                         
standard or other volumetric manipulation 
• solids must be dissolved or extracted 
• Samples that require pretreatment to remove interference and / or to protect the 
column or equipment from damage 
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4. Appropriate choice of the column: 
The selection of the column in HPLC is somewhat similar to the selection of 
column in G.C, in the sense that, in the adsorption and partition modes, the 
separation mechanism is based on inductive forces, dipole-dipole interaction and 
hydrogen bond information. 
Column plays the important role in achieving the chromatographic 
separation.  
The following parameters should be considered while selecting a column:  
i. length and diameter of the column 
ii. packing material 
iii. size and shape of the particles 
iv. pore size, surface area and end capping 
v. percentage of carbon loading 
Columns with silica as a packing material used widely in normal phase 
chromatography, where the eluent (mobile phase) is non-polar consisting of various 
organic solvents and the stationary phase is polar. The silanol groups on the surface 
of the silica give it a polar character. 
In reverse phase chromatography a wide variety of columns is available 
covering a wide range of polarity by cross linking the silanol groups with alkyl 
chains like C6, C8, C18 and Nitrile groups (-CN), phenyl groups (-C6H6) and amino 
groups (-NH2) 
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ORDER OF THE SILICA BASED COLUMNS 
                                I------Non polar------Moderately polar------Polar------I 
                                C18<C8<C6< Phenyl < Amino < Cyano <Silica 
5. Selection of flow rate. 
Flow rate is selected based on the follows: 
• Retention time 
• Column composition 
• Separation impurities 
• Peak symmetry 
Preferably flow rate shall not be more than 2.5 ml/min. a flow rate that gives 
least retention times, good peak symmetries, least back pressure and better 
separation of impurities from API peak shell be selected. 
6. Selection of detector wavelength: 
Selection of detector wavelength is a critical step in finalization of the 
analytical method. To determine the exact wavelength standard API is injected into 
chromatographic system with photo Diode array detector and the wavelength, which 
gives higher response for the Compound 
7. Selection of column temperature: 
Ambient temperature is always preferred as a column temperature. However 
if the peak Symmetry could not be achieved then the column temperature can be 
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varied between 300To
 800 c. if a column temperature above 800c is found necessary, 
packing material which can Withstand to that temperature shall be chosen. The 
increase in column temperature generally will result in reduction in peak asymmetry 
and peak retentions. 
1.5ANALYTICAL METHOD VALIDATION: 
Method validation can be defined as (ICH) “Establishing documented 
evidence, which provides a high degree of assurance that a specific activity will 
consistently produce a desired result or product meeting is predetermined 
specifications and quality characteristics”. 
Method validation study include system suitability, linearity, precision, 
accuracy, specificity,  ruggedness, robustness, limit of detection, limit of 
quantification and stability of samples, reagents, instruments. 
VALIDATION DEFINITION: 
FDA defines validation as “Establishing documented evidence, which 
Provides a high degree of degree of assurance that a specific process will 
consistently produce a product of predetermined specifications and quality 
attributes. 
OBJECTIVE OF METHOD VALIDATION: 
The objective of validation is to form a basis for written procedure for 
production and control, which are designed to assure that the drug products have the 
identity, Quality, and purity. 
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TYPES OF ANALYTICAL PROCEDURES: 
i. Identification tests 
ii. Quantitative tests for impurities content 
iii. Limit test for control of impurities 
iv. Quantitative tests of the active moiety in samples of drug substances or drug 
product or             
v. Other selected components(s) in the drug product. 
vi. Dissolution testing for drug products 
vii. Particle size determination for drug substances. 
6. VALIDATION PARAMETERS (ICH). 
  Typical validation study include system suitability 
I. Accuracy 
II. Precision 
III. Specificity 
IV. Linearity 
V. Detection limit 
VI. Quantitation limit 
VII. Range 
VIII. Robustnes 
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1. System suitability 
Prior to the analysis of samples of each day, the operator that the HPLC 
system and procedure are capable of providing data of acceptable quality. This is 
accomplished with system suitability experiments, which can be defined as tests to 
ensure that the method can generate results of acceptable accuracy and precision. 
The requirements for system suitability are usually developed after method 
development and validation has been completed. 
Table: 6. System suitability parameters and Recommendation 
Parameter Recommendation 
Capacity factor The peak should be well-resolved  from Other peaks and 
the void volume,  Generally K>2.0 
Repeatability RSD ≤1% N ≥ 5 is desirable 
Relative retention Not essential as long as the resolution is Stated 
Resolution RS of >2 between the peak interest and The closes to 
eluting potential Interference (impurity, excipient, 
degradation product, internal standard, etc,) 
Tailing factor T of ≤ 2 
Theoretical plates N> 2000 
 
Non-Interference of placebo: 
The portion of specificity evaluation applies to the finished drug product 
only.Excipients present in the formulation should be evaluated and must not 
interfere with the detection of the analyte. 
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2. Linearity 
The linearity of a method is a measure of how well a calibration plot of 
response VS concentration approximates a straight line. Linearity can be assessed by 
performing Single measurement at several analyte concentrations. The data is then 
processed using a linear least- squares regression. The resulting plot slope, intercept 
and correlation coefficient provide the desired information on linearity. 
3. Precision 
Precision can be defined as “The degree of agreement among individual test 
results when the procedure is applied repeatedly to multiple samplings of a 
homogenous sample”. A More comprehensive definition proposed by the 
international conference on Harmonization (ICH) divides precision into three types. 
1. Repeatability 
2. Intermediate precision and 
3. Reproducibility 
Repeatability: is the precision of a method under the same operating conditions 
over a short period of time. 
Intermediate precision: is the agreement of complete measurements (including 
standards) when the same method is applied many times within the same laboratory. 
Reproducibility: examine the precision between laboratories and is often 
determined in collaborative studies or method transfer experiments. 
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4. Accuracy: 
 The accuracy of a measurement is defined as the closeness of the measured 
value to the true value. In a method with high accuracy, a sample (whose “true 
value” is known) is analyzed and the measured value is identical to the true value. 
Typically, accuracy is represented and determined by recovery studies.  
There are three ways to determine accuracy: 
1. Comparison to a reference standard 
2. Recovery of the analyte spiked into black matrix or 
3. Standard addition of the analyte. 
It should be clear how the individual or total impurities are to be determined. e.g., 
weight/ weight or area percent in all cases with respect to the major analyte. 
5. Specificity/ selectivity 
The terms specificity are often used interchangeably. According to ICH, the 
term specific    generally refers to a method that produces a response for a single 
analyte only while the term selective refers to a method which provides responses 
for a number of chemical entities that may or may not be distinguished from each 
other. If the response is distinguished from all other responses, the method said to be 
selected. Since there are very few methods that respond to only one analyte, the term 
selectivity is more appropriate. The analyte should have no interference from other 
extraneous components and be well resolved from them. A representative 
chromatogram or profile should be generated and submitted to show that the 
extraneous peak either by addition of known compounds or samples from stress 
testing are baseline resolved from the parent analyte. 
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6. Ruggedness: 
 The  ruggedness of an analytical method is the degree of reproducibility of 
test results Obtained by the analysis of the same samples under a variety of normal 
test conditions such as different laboratories, different analysts, using operational 
and environmental Conditions that may differ but are still within the specified 
parameters of the assay. The testing of the ruggedness is normally suggested when 
the method is to be used in more than one laboratory. Ruggedness normally 
expressed as the lack of the influence on the test results of operational and 
environmental variables of the analytical method. 
For the determination or ruggedness, the degree of reproducibility of test 
result is determined as a function of the assay variable. This reproducibility may be 
compared to the precision of the assay under normal conditions to obtain a measure 
of the ruggedness of the analytical method. 
7. Robustness: 
The concept of robustness of an analytical procedure has been defined by the 
ICH as “a Measure of its capacity to remain unaffected by small, but deliberate 
variations in method Parameters”. A good practice is to vary important parameters 
in the method systematically and measure their effect on separation. The variable 
method parameters in HPLC technique may involve flow rate, column temperature, 
sample temperature, pH and mobile phase composition. 
8. Stability: 
             To generate reproducible and reliable results, the samples, standards, and 
Reagents used for the HPLC method must be stable for a reasonable time (e.g., one 
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day, One week, and one month, depending on need). Therefore, a few hours of 
standard and sample solution suitability can required even for short (10 min) 
separation. When more than one sample is analyzed (multiple lots of one sample or 
samples from different storage conditions from a single lot), automated, overnight 
runs often are performed for better lab efficiency such practices add requirements 
for greater solution stability. 
9. Limit of Detection: 
                Limit of detection (LOD) is the lowest concentration of analyte in a 
sample that can be detected, but the necessarily quantitated, under the stated 
experimental conditions.  
• Based on visual Evaluation 
• Based on the standard Deviation of the Blank 
• Based on the calibration curve 
• Based on signal-to-noise: A signal-to-noise ratio of 3 or 2:1 is acceptable 
 LOD may be expressed as 
LOD =3.3σ/s 
Where,           σ = the standard deviation of the response 
                       S= the slope of the calibration curve 
The slope S may be estimated from the calibration of the analyte. 
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10. Limit of quantitation:  
 Limit of quantitation is the lowest concentration of analyte in a sample that 
can be Determined with acceptable precision and accuracy under the stated 
experimental conditions. Several approaches for determining the quantification limit 
are possible. 
• Based on visual Evaluation 
• Based on standard Deviation of the blink 
• Based on the calibration curve 
• Based on the signal-to-Noise Approach: A typical signal-to-Noise is 10:1 
LOQ may be expressed as   
LOQ = 10σ /s 
          Where, σ = standard deviation of the response 
                       S= the slope of the calibration curve 
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2. LITERATURE REVIEW 
1. Enjem Karunaker Reddy et al.; An isocratic, reversed phase-liquid-
chromatographic method was developed for the quantitative determination of 
Azithromycin and Levofloxacin in combined-dosage form. A Waters Symmetry 
Shielde Rp18, (250*4.6*5µ) column with mobilephase containing water pH 9.2 
adjusted with di- Potassium hydrogen Phosphate: Methanol in the ratio of (60: 40, 
v/v) was used.The flow rate was 1.0 mL/min, column temperature was 30°C and 
effluents were monitored at 285 nm. The retention times of Azithromycin and 
Levofloxacin were 5.001min and 3.232min, respectively. The correlation co-
efficient for Azithromycin andLevofloxacin was found to be 0.99 and 0.99, 
respectively. The proposed method was validated with respect to linearity, 
accuracy,precision, specificity, and robustness. Recovery of Azithromycin and 
Levofloxacin in formulations was found to be in the range of97-103% and 97-103% 
respectively confirms the non-interferences of the excipients in the formulation. Due 
to its simplicity,rapidness and high precision. The method was successfully applied 
to the estimation of Azithromycin and Levofloxacin in combined dosage form. 
2. Yun Nairu1 et al.; A RP-HPLC method was developed for the determination of 
Levofloxacin and Azithromycin in CM129 medium,in order to provide an Analysis 
Method to Experiment which Azithromycin promote Levofloxacin to penetrate 
biomembrane.Method  The analytical column was Waters C18.The mobile phase 
consisted of which methanol monopotasium phosphate buffer=29∶71(pH=2.53).The 
flow rate was 1.0 ml/min,and the detector was set at UV 210 nm.Results : The 
calibration curve was linear in the range of 10～160 µg/ml,Correlation coefficient of 
the both two drug was 0.999 9 respectively,the average recovery of Levofloxacin 
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was 99.83% with RSD of 1.08% and the average recovery of Azithromycin was 
100.34% with RSD of 0.47%.Conclusion : This method has been applied to the 
determinate the concentrations of Levofloxacin and Azithromycin simultaneously. 
3. M. Rachidi et al.; Azithromycin (AZT), an antibiotic belonging to the family of 
macrolides, can be analyzed by a new spectrophotometric method based on the 
formation of an ion pair between this drug and an inorganic complex of (Mo(V)–
thiocyanate) followed by its extraction with dichloroethane. This ion‐association 
complex shows an orange color and exhibits a maximum absorbance at 469 nm. The 
experimental conditions of the reaction were studied and optimized. The calibration 
graph was linear (r=0.9996) over the range 10−6 M–10−5 M of AZT. This simple and 
validated method has been successfully applied to the determination of azithromycin 
in pharmaceutical formulations with a mean relative standard deviation of 1.07% 
and mean recovery of 99.66%. The common excipients present in azithromycin 
formulations did not interfere in its determination. This new spectophotometric 
method has been applied successfully to illustrate the dissolution profiles of original 
tablets and generic compounds; hence, it could be employed in routine quality 
control of azithromycin in pharmaceutical dosage forms.. 
4. S.C. Arora et al.; Azithromycin Dihydrate (Poorly water soluble drug), when 
prepared as solid dispersion showed improved solubility and dissolution. So the 
main purpose of this investigation was to increase the solubility and dissolution rate 
of Azithromycin Dihydrate by the preparation of its solid dispersion with urea using 
solvent evaporation method. Physical mixtures and solid dispersions of 
Azithromycin Dihydrate were prepared by using urea as water-soluble carrier in 
various proportions (1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7 by weight), by employing 
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solvent evaporation method. The drug release profile was studied and it was found 
that the dissolution rate and the dissolution parameters of the drug from the physical 
mixture as well as solid dispersion were higher than those of the intact drug. FT- IR 
spectra revealed no chemical incompatibility between drug and urea. Drug-polymer 
interactions were investigated using differential scanning calorimetry (DSC) and 
Powder X-Ray Diffraction (PXRD). 
5. Makarand Avhad et al.; An accurate, specific and precise UV 
spectrophotometric method was developed for the simultaneousdetermination of 
levofloxacin (LVF) and ambroxol (AMB) in pharmaceutical dosage forms. The 
method involves formation ofQ-absorbance equation at 219 (isoabsorptive point) 
and at 287 nm, using distilled water as a solvent. The linearity for bothlevofloxacin 
and ambroxol was in the range of 2-14 µg/ml and 5-35 µg/ml respectively. The % 
recovery was found to be 100-101% and 101-102% for levofloxacin and ambroxol 
respectively indicating proposed method is accurate and precise forsimultaneous 
estimation of levofloxacin and ambroxol in tablets. 
6.S. Schulte et al.; A simple, accurate, sensitive, and precise reversed-phase (RP) 
high-performance liquid chromatographic (HPLC) method with fluorescence 
detection allowing the sensitive and specific quantitation of the newer 
fluoroquinolones levofloxacin and moxifloxacin is described. Moxifloxacin is used 
as the internal standard for the determination of levofloxacin and vice versa. A 
single-step liquid-liquid extraction from human plasma is sufficient for both 
quinolones. The method is linear from 0.1 to 15 µg/mL and 0.2 to 7 µg/mL for 
levofloxacin and moxifloxacin, respectively, covering the clinically relevant plasma 
concentration range. The limits of quantitation are 0.05 µg/mL (levofloxacin) and 
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0.2 µg/mL (moxifloxacin). The method is successfully applied to plasma drug level 
monitoring in a volunteer receiving single therapeutic doses of levofloxacin or 
moxifloxacin at two different occasions. 
7. M. Senthil Raja1 et al.; A simple reverse phase liquid chromatographic method 
has been developed and subsequently validated for simultaneous determination of 
Azithromycin and Ambroxol Hydrochloride in combined dosage form. 
Theseparation was carried out using a mobile phase consisting of acetonitrile and 
mono basic potassium phosphate buffer of pH 8.5 in the ratio of 65:35 v/v. The 
column used was C18 phenomenex Gemini 5m, 250cm x 4.6mm id with flow rate 
of2ml/min using PDA detection at 220nm. The described method was linear over a 
concentration range of 96-145mg/mland 80-125mg/ml for the assay of 
Azithromycin and Ambroxol Hydrochloride respectively. The retention times of 
Ambroxol and Azithromycin were found to be 3.7min and 6.1min respectively. 
Results of analysis were validatedstatistically and by recovery studies. The limit of 
quantification (LOQ) for Azithromycin and Ambroxol Hydrochloridewere found to 
be 96.7mg/ml and 8.35mg/ml respectively. Then the limit of detection (LOD) for 
Azithromycin and Ambroxol Hydrochloride were found to be 31.91 mg/ml and 2.75 
mg/ml respectively. 
8. Vishal Shah et al.; A novel, simple, accurate, sensitive, reproducible, economical 
spectroscopic methodwas developed and validated for the determination of 
Azithromycin dihydrate andCefixime trihydrate in combined dosage form. Second 
order derivative spectroscopymethod is adopted to eliminate spectral interference. 
The method obeys Beer’s Law inconcentration ranges of 10-40 ppm for Cefixime 
trihydrate and 25-100 ppm of Azithromycin dihydrate. The method was validated 
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for linearity, accuracy andprecision as per ICH guidelines. The zero crossing point 
for Azithromycin dihydrateand Cefixime trihydrate was 328 nm and 231.6 nm, 
respectively in water. The LODand LOQ value were found to be 0.13 and 0.38 ppm 
for Cefixime trihydrate and 0.80and 2.44 ppm for Azithromycin dihydrate 
respectively. 
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3.1 LEVOFLOXACIN
It inhibits bacterial type II topoisomerases, topoisomerase IV and DNA gyrase.
Structure: 
IUPAC Name 
  
  
Molecular formula   
Molecular Weight   
Solubility         
 Pka                           
Mechanism of action:
 Levofloxacin inhibits bacterial type II topoisomerases, topoisomerase IV and 
DNA gyrase. Levofloxacin, like other fluoroquinolones, inhibits the A subuni
DNA gyrase, two subunits encoded by the gyrA gene. This results in strand 
breakage on a bacterial chromosome, supercoiling, and resealing; DNA replication 
and transcription is inhibited.
 40 J.K.K.Nattraja College of Pharmacy
3. DRUG PROFILE 
 
 
Fig no:3 Structure of Levofloxacin 
: (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin
 oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca
 5(13),6,8,11-tetraene-11-carboxylic acid 
: C18H20FN3O4 
: 361.3675 /mol 
: slightly soluble in water, soluble in glacial acetic acid.
: 5.45 
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Indications: For the treatment of bacterial conjunctivitis caused by susceptible 
strains of the following organisms: Corynebacterium species, Staphylococus 
aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus 
(Groups C/F/G), Viridans group streptococci, Acinetobacter lwoffii, Haemophilus 
influenzae, Serratia marcescens.. 
Absorption: Absorption of ofloxacin after single or multiple doses of 200 to 400 
mg is predictable, and the amount of drug absorbed increases proportionately with 
the dose. 
Protein binding: 24-38% (to plasma proteins)  
Metabolism: Mainly excreted as unchanged drug (87%); undergoes limited 
metabolism in humans.  
Pharmacodynamics: Levofloxacin, a fluoroquinolone antiinfective, is the optically 
active L-isomer of ofloxacin. Levofloxacin is used to treat bacterial conjunctivitis, 
sinusitis, chronic bronchitis, community-acquired pneumonia and pneumonia caused 
by penicillin-resistant strains of Streptococcus pneumoniae, skin and skin structure 
infections, complicated urinary tract infections and acute pyelonephritis.  
Half Life: 6-8 hours  
Route of elimination: 
 Mainly excreted as unchanged drug in the urine.  
Toxicity: 
 Side effects include disorientation, dizziness, drowsiness, hot and cold 
flashes, nausea, slurring of speech, swelling and numbness in the face 
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3.2 AZITHROMYCIN
 It binds to the 50S subunit of the 70S bacterial ribosomes, and therefore 
inhibits RNA-dependent protein synthesis in bacterial cells.
Structure: 
IUPAC Name: (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)
(dimethylamino)-3-hydroxy
{[(2R,4R,5S,6S)-5-hydroxy
3,5,6,8,10,12,14-heptamethyl
Molecular formula 
Molecular Weight     
Solubility 
 
Pka 
Mechanism of action:
 Azithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and 
therefore inhibits RNA
 Absorption: 
Absorption is not affected by food. Azithromycin is ext
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Fig no:4 Stuctue of Azithromycin 
-11-{[(2S,3R,4S,6R)
-6-methyloxan-2-yl]oxy}-2-ethyl-3,4,10
-4-methoxy-4,6-dimethyloxan-2-yl]oxy}
-1-oxa-6-azacyclopentadecan-15-one 
: C38H72N2O12  
: 748.9845 gm/mol 
: Freely soluble in methanol, slightly soluble in 
 95%ethonol, very slightly soluble in water
: 8.74 
 
-dependent protein synthesis in bacterial cells..
Bioavailability is 37% following oral administration. 
ensively distributed in tissues 
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with tissue concentrations reaching up to 50 times greater than plasma 
concentrations. Drug becomes concentrated within macrophages and 
polymorphonucleocytes giving it good activity against Chlamydia trachomatis. 
 Protein binding: Serum protein binding is variable in the concentration 
range approximating human exposure, decreasing from 51% at 0.02 µg/mL to 7% at 
2 µg/mL. 
 Metabolism: Hepatic. In vitro and in vivo studies to assess the metabolism 
of azithromycin have not been performed. 
Pharmacodynamics: 
 Azithromycin, a semisynthetic antibiotic belonging to the macrolide 
subgroup of azalides, is used to treat STDs due to chlamydia and gonorrhea, 
community-acquired pneumonia, pelvic inflammatory disease, pediatric otitis media 
and pharyngitis, and Mycobacterium avium complex (MAC) in patients with 
advanced HIV disease. Similar in structure to erythromycin. azithromycin reaches 
higher intracellular concentrations than erythromycin, increasing its efficacy and 
duration of action. 
Route of elimination: 
 Biliary excretion of azithromycin, predominantly as unchanged drug, is a 
major route of elimination. 
Half life: 68 hours 
Toxicity: Potentially serious side effects of angioedema and cholestatic jaundice 
were reported.      
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AIM AND OBJECTIVE 
 4. 1 AIM & OBJECTIVE 
Existing literature reveals that Levofloxacin and Azithromycin can be 
analyzed by UV detection, HPTLC, HPLC individually and combination with other 
drugs in bulk material and pharmaceutical forms. 
A comprehensive, validated and simple analytical simultaneous method 
development and validation of Levofloxacin and Azithromycin is, therefore, crucial. 
No economic, simple and precise HPLC method was there for simultaneous 
estimation of Levofloxacin and Azithromycin in bulk and pharmaceutical dosage 
forms. Therefore, in proposed project a successful attempt has been made to 
develop, simple, Accurate, and economic methods for analysis of Levofloxacin and 
Azithromycin tablets validated. 
OBJECTIVE 
The objective of the present work is to development and validates a HPLC 
method development and validation Levofloxacin and Azithromycin of tablets. To 
be employed in routine analysis.In the method development of Levofloxacin and 
Azithromycin we have decided to carry out our project work by incorporating the 
Reverse phase High performance Liquid chromatography (HPLC).Then the 
developed method will be validated according to ICH guidelines for its various 
parameters. 
 
Chapter 5 Plan of Work 
Dept of Pharmaceutical Analysis 45 J.K.K.Nattraja College of Pharmacy 
PLAN OF WORK 
In order to develop a simple, reliable and an accurate method development 
and validation of Levofloxacin and Azithromycin in pharmaceutical dosage form by 
Reverse phase HPLC and validate the method for its repeatability and 
reproducibility  
Plan of the proposed work includes the following steps: 
• Selection of drug and literature survey. 
• Solubility studies and optimization of conditions. 
• Analytical method(s) development using HPLC etc., 
• Assay of the drugs(s) in marketed formulations using the proposed method(s). 
• Procurement of raw materials. 
• Establishment of system suitability parameters. 
• Trails for the method development of Levofloxacin and Azithromycin Setting 
of the optimized method. 
• Validation of the optimized method for Levofloxacin and Azithromycin  
Validation parameters include 
 System suitability 
 Specificity 
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 precision 
 Linearity 
 Accuracy 
 Range 
 Ruggedness 
 Robustness 
 Assay 
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MATERIALS AND METHODS 
6.1 INSTRUMENTS/EQUIPMENT USED 
Instruments: 
• WATERS HPLC, Model: Aglient 2695, Photo diode array detector (PDA), with 
an automated sample injector. The output signal was monitored and integrated 
using Empower 2 software.ELIPSE C8 (150mm*4.6, 5 µm, Make: Waters) 
column was used for separations. 
Table 7 : List of Equipments 
S.NO Equipment’s Model Company 
     1 Electronic Balance ER200A ASCOSET 
     2 Ultra-Sonicator SE60US ENERTECH 
     3 Heating Mantle BTI BIO TECHNICS INDIA 
     4 Thermal oven --------- NARANG 
     5 pH Meter AD102U ADWA 
     6 Filter Paper 0.45     
microns --------- MILLI PORE 
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6.2 CHEMICALS AND REAGENTS USED 
Table no.8: List of chemicals and reagents used 
S. No. Chemicals/standards and reagents Grade Make 
1 KH2PO4 AR Finar 
2 Methanol HPLC Merck 
3 Water HPLC Loba Chemi 
4 DiPotassium hydrogen phosphate AR Dr. Reddy’s 
5 Levofloxacin NA Dr. Reddy’s 
6 Azithromycin NA Dr. Reddy’s 
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5.3 METHOD DEVELOPMENT  
The UV spectrums of Levofloxacin and Azithromycin under these mobile 
phase conditions were shown below and from these spectrums, Lambda Max  265 
nm were observed. 
 
  
3.157 Peak 1
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METHOD DEVELOPMENT TRAILS: 
Trial-1 
Mobile Phase : 0.1%OPA: Methanol (600:400) 
Column : Agilent ZorbaxC18, 250x4.6, 5µ 
Flow Rate : 1.0ml/min 
Injection Volume : 10 µl 
Column Temperature : 30˚C 
Detector : 265nm 
 
Fig. no.8: Typical chromatogram of trail 1 
 
Observation: There is no second peak 
Reason: May low Concentration 
May be insoluble of Drug 
3.
15
6
AU
0.00
0.20
0.40
Minutes
0.00 1.00 2.00 3.00 4.00 5.00 6.00
 Name Retention Time Area USP Tailing USP Plate Count 
1 Levofloxacin 3.156 1863337 1.61 10517 
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Trial-2 
Mobile Phase : 0.1%OPA: Methanol (600:400) 
Column : Agilent ZorbaxC18, 250x4.6, 5µ 
Flow Rate : 1.0ml/min 
Injection Volume : 10 µl 
Column Temperature : 30˚C 
Detector : 265nm 
 
Fig. no. 9: Typical chromatogram of trail 2 
 
Observation: Even there is no second peak  
Reason: May be Mobile Phase Ph problem  
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0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80
 Name Retention 
Time 
Area USP Tailing USP Plate Count 
1 Levofloxac
in 
2.266 16013611 0.92 5191 
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Trial-3 
Mobile Phase : KH2PO4: Methanol (800:200) 
Column : Agilent ZorbaxC18, 250x4.6, 5µ 
Flow Rate : 1.0ml/min 
Injection Volume : 10 µl 
Column Temperature : 30˚C 
Detector : 265nm 
 
Fig. no.10: Typical chromatogram of trail 3 
 Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
1 Levofloxac
in 
3.456 1655193  0.72 8570 
2 Azithromy
cin 
8.558 182768 20.25 1.07 10061 
 
Observation: Yes we got two peaks with good resolution but second peak response 
is very poor. 
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Trial-4 
Mobile Phase : KH2PO4: Methanol (600:400) 
Column : Agilent ZorbaxC18, 250x4.6, 5µ 
Flow Rate : 1.0ml/min 
Injection Volume : 10 µl 
Column Temperature : 30˚C 
Detector : 265nm 
 
Fig. no.11: Typical chromatogram of trail 4 
 
Observation: Yes we got two peaks but low resolution  
Reason: May be buffer volume low in Mobile Phase 
3.
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00
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0.06
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00
 Name Retention 
Time 
Area USP 
Resolution 
USP Tailing USP Plate 
Count 
1 Levofloxaci
n 
3.936 520470  1.21 5853 
2 Azithromyc
in 
5.006 928473 3.69 1.20 3726 
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Trial-5 
Mobile Phase : K2HPO4: Methanol (400:600) 
Column : Agilent ZorbaxC18, 250x4.6, 5µ 
Flow Rate : 1.0ml/min 
Injection Volume : 10 µl 
Column Temperature : 30˚C 
Detector : 265nm 
 
Fig. no. 12: Typical chromatogram of trail 5 
 
Observation: Yes we got two peaks but low resolution  
Reason: May be buffer volume low in Mobile Phase 
2.
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 Name Retention 
Time 
Area USP 
Resolution 
USP Tailing USP Plate 
Count 
1 Levofloxacin 2.620 4512330  1.36 3875 
2 Azithromycin 2.930 2417939 1.71 0.95 4874 
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Trial-6 
Mobile Phase : K2HPO4: Methanol (400:600) 
Column : Agilent ZorbaxC18, 250x4.6, 5µ 
Flow Rate : 1.0ml/min 
Injection Volume : 10 µl 
Column Temperature : 30˚C 
Detector : 265nm 
 
Fig. no. 13: Typical chromatogram of trail 6 
 Name Retenti
on 
Time 
Area USP 
Resoluti
on 
USP 
Tailing 
USP Plate 
Count 
1 Levofloxacin 3.154 1058576 2.33 1.35 14206 
2 Azithromycin 3.436 1022805  1.55 11075 
 
Observation: 
RT was found to be good and the peak symmetry of both drugs were good. 
And the resolution theoretical plate count and tailing were within the limits and it is 
used for validation of the method. 
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OPTIMIZED METHOD 
Chomatographic parameters: 
Mobile Phase :  K2HPO4: Methanol (400:600) 
Column : Agilent ZorbaxC18, 250x4.6, 5µ 
Flow Rate : 1.0ml/min 
Injection Volume : 10 µl 
Column Temperature : 30˚C 
Detector : 265nm 
Procedure: 
Inject 10µL of standard, sample into chromatographic system and measure 
the areas for the Levofloxacin and Azithromycin peaks and calculate the % assay by 
using the formula 
 
Fig. no.14: Chromatogram for optimized method 
 Name Retenti
on 
Time 
Area USP 
Resoluti
on 
USP 
Tailing 
USP Plate 
Count 
1 Levofloxacin 3.154 1058576 2.33 1.35 14206 
2 Azithromycin 3.436 1022805  1.55 11075 
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Observation:  
 Peeks are well separated all the parameters are within the limits. For 
quantitative analytical purpose wavelength was set at 265 nm, which provided better 
reproducibility. 
PREPARATION OF MOBILE PHASE: 
Transfer 500ml of HPLC water into 500ml of beaker and  DiPotassium 
hydrogen phosphate adjust pH 3.5 using O-phosphoric acid. Transfer the above 
solution 400mlof K2HPO4, 600ml of Methanol is used as mobile phase. They are 
mixed and sonicated for 20min. 
PREPARATION OF THE LEVOFLOXACIN AND AZITHROMYCIN 
STANDARD AND SAMPLE SOLUTION: 
PREPARATION OF STANDARD SOLUTION: 
Accurately weigh and transfer 100mg of Levofloxacin and Azithromycin into 
100ml of volumetric flask and add 10ml of Methanol and sonicate 10min (or) shake 
5min and make with water. Transfers the above solution into 5ml into 50ml 
volumetric flask dilute to volume with water. 
PREPARATION OF SAMPLE STOCK SOLUTION: 
Commercially available 20 tablets ware weighed and powdered the 
powdered equivalent to the 500mg of Levofloxacin and Azithromycin of active 
ingredients were transfer into a 100ml of volumetric flask and add 10ml of Methanol 
and sonicate 20min (or) shake 10min and makeup with water. Transfers above 
solution 5ml into 50ml of the volumetric flask dilute the volume with Methanol. 
And the solution was filtered through 0.45µm filter before injecting into HPLC 
system. 
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6.4 ASSAY RESULT FOR FORMULATION 
Label contains: Each film coated tablet contains 
Levofloxacin  - 500mg. 
 Azithromycin -500 mg. 
Average weight of each tablet is 1383.0mg 
Purity of working standards: 
 1. Levofloxacin: %purity-99.1% 
2. Azithromycin: % purity –99.7% 
Sample preparation: 
10 tablets were weighed and crushed, from the powdered tablets, weighed 
accurately about 500mg(500mg Levofloxacin and 500mg Azithromycin) into a 100 
ml volumetric flask and 50 ml of mobile phase was added. The mixture was 
subjected to sonication for 20 min with intermediate shaking for complete extraction 
of drugs. Filtered and cooled to room temperature and solution was made up to mark 
with mobile phase. From the above solution 5 mL is taken and further diluted in 25 
ml volumetric flasks with mobile phase. To acquire a concentration of 500mg 
Levofloxacin and 500mg Azithromycin. 
Standard preparation: 
Accurately weighed quantity of 500mg Levofloxacin and 500mg 
Azithromycin was taken in a 100 ml volumetric flask and 50 ml of mobile phase 
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was added. The mixture was subjected to sonication for 20 min with intermediate 
shaking for complete extraction of drugs. Filtered and cooled to room temperature 
and solution was made up to mark with mobile phase. From the above solution 5 ml 
is taken and further diluted in 25 mL volumetric flasks with mobile phase.To acquire 
a concentration of 500mg Levofloxacin and 500mg Azithromycin.  
Procedure: 
Separately injected both the standard (2 injections) and sample preparations 
(2 injections) into the chromatographic system and recorded the peak area responses.   
% percentage content =  
Sample area×Sample dilution ×Avg weight×standard weight ×purity of working 
standard ×100 
Standard area ×standard dilution×label claim × sample weight 
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6.5 METHOD VALIDATION 
1. SYSTEM SUITABILITY: 
 Tailing factor for the peaks due to Levofloxacin and  Azithromycin in standard 
solution should not be more than 2.0.Theoretical plates for the Levofloxacin and  
Azithromycin peaks in standard solution should not be less than 2000. 
2. SPECIFICITY: 
 Solution of standard, sample, blank and placebo were prepared as per test 
procedure and injected into the HPLC system.  
Acceptance criteria: 
 Chromatogram of standard and sample should be identical with near 
Retention time. 
Blank interference: 
 A study to establish the interference of blank was conducted. Diluent was 
injected into HPLC system as per the test procedure. 
Acceptance criteria: 
 Chromatogram of blank should not show any peak at the retention time of 
analytepeak. There is no interference due to blank at the retention time of analyte. 
Hence the method is specific. 
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3. LINEARITY 
 Prepare a series of standard solutions and inject into HPLC system. Plot the 
graph of standard versus the actual concentration in µg/ml and determine the 
coefficient of correlation and basis for 100% response. 
Acceptance criteria: 
 Linearity regression coefficient of average peak area response of replicate 
injections plotted against respective concentration should not be less than 0.999. The 
% y-intercept as obtained from the linearity data (without extrapolation through 
origin 0, 0) should be within ±2.0. 
Statistical Evaluation: 
 A graph between the concentration and the average area was plotted. Points 
for linearity were observed. Using the method of least squares, a line of best fit was 
taken and the correlation Coefficient, slope and, y-intercept were calculated.  
4. PRECISION: 
Preparation of sample: 
 Transfer the 200.5mg of sample into a 100ml of volume at flask and add 
10ml of water and 10ml of Methanol and sonicate 20min and makeup with 
water. Transfer the above solution into 5ml into 50ml volume metric flask 
dilute to the volume with water. 
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 The method precision parameters were evaluated from sample 
chromatograms obtained, by calculating the % RSD of peek areas from 6 
replicate injection. 
Acceptance criteria: The injection reproducibility requirements are met if the 
%RSD for peak areas is not more than 2.0 and for retention times is not more than 
2.0. 
5. RECOVERY/ACCURACY 
  Recovery study can be performed in the concentration range of 80% to 
120% of the target concentration of the test. Minimum 3 concentrations are 
recommended. 
Acceptance criteria: 
 The average percentage recovery was between 98-102% and Relative 
standard deviation of these recovery concentrations was less than 2%. 
6. LIMIT OF DETECTION 
 The sensitivity of measurement of Levofloxacin and  Azithromycin by use of 
proposed method was estimated in terms of the limit of detection (LOD). The LOD 
was calculated by the use of signal to noise ratio. In order to estimate the LOD 
value, the blank sample was injected six times and peak area of this blank was 
calculated as noice level. The LOD was calculated as three times the noise level. 
                                                LOD= 3.3 σ / S 
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Where, 
σ  = standard deviation of intercepts of calibration curves 
S = mean of slopes of the calibration curves 
The slope S may be estimated from the calibration curve of the analyte. 
7. LIMIT OF QUANTITATION: 
 The sensitivity of measurement of Levofloxacin and  Azithromycin by the use of 
proposed method was estimated in terms of limit of quantitation (LOQ). The LOQ 
was calculated by the use of signal to noise ratio. In order to estimate the LOQ 
value, the blank sample was injected six times and the peak area of this blank was 
calculated at noise level. The LOQ was calculated as ten times the noise value gave 
the LOQ. 
LOQ = 10 σ / S 
Where, 
σ  = standard deviation of intercepts of calibration curves 
S = mean of slopes of the calibration curves 
The slope S may be estimated from the calibration curve of the analyte. 
8. ROBUSTNESS: 
Effect of variation in flow rate: 
 Prepare the system suitability solution as per the test method and inject into 
the HPLC system with ±0.2 ml of the method flow. Evaluate the system suitability 
values as required by the test method for both flow rates. Actual flow rate was 1.0 
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ml/min and it was changed to 0.8ml/min and 1.2ml/min and inject into HPLC and 
system suitability was checked. 
Effect of variation in wavelength: 
 Prepare the system suitability solution as per the test method and injected 
into the HPLC with    ±2nm variation in wavelength. Evaluate the system suitability 
values as required by the test method for both wavelengths. 
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7. RESULTS AND DISCUSSION 
1. SYSTEM SUITABILITY: 
Table 9: System suitability data of Levofloxacin and Azithromycin 
parameter Levofloxacin Azithromycin Acceptance 
criteria 
Retention time 3.154  3.436 +-10 
Theoretical plates 14206  11075 >2500 
Tailing factor 1.35 1.55 <2.00 
% RSD 0.3 0.2 <2.00 
                            
  Table 10 : Standard Results of Levofloxacin 
S.no  Sampl name RT Area USP plate count USP tailing  
1. Injection1 3.154 1136532 11143 1.49 
2. Injection 2 3.153 1142370 10970 1.51 
3. Injection 3 3.151 1134603 11208 1.47 
4. Injection 4 3.149 1139792 11201 1.50 
5. Injection 5 3.149 1132720 11369 1.48 
 
Table 11 :  Standard Results of Azithromycin 
S.no  Sample 
name 
RT Area  USP plate 
count 
USP 
tailing 
1. Injection 1 3.439 1110718 13998 1.30 
2. Injection 2 3.438 1115155 14170 1.31 
3. Injection 3 3.439 1115740 14068 1.31 
4. Injection 4 3.435 1111439 14266 1.31 
5. Injection 5 3.434 1112680 14175 1.30 
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            typical Chromatogram of Standard-2; Injection-1 
 
 typical Chromatogram of Standard-2; Injection-2 
 
typical Chromatogram of Standard-2; Injection-3 
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        typical Chromatogram of Standard-2; Injection-4 
 
typical Chromatogram of Standard-2; Injection 5 
 
         Typical Chromatogram of Standard-1 
RESULT 
Results of system suitability study are summarized in the above table. Six 
consecutive injections of the standard solution showed uniform retention time, 
theoretical plate count, tailing factor and resolution for both the drugs which indicate 
a good system for analysis. 
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2. SPECIFICITY: 
Table 12 : Specificity data for Levofloxacin and Azithromycin 
 
                    
Typical chromatogram of the blank 
 
Typical chromatogram of the Placebo 
S no Sample name Levofloxacin  
area 
Rt Azithromycin 
Area 
Rt 
1 Standard 1136532 3.154 1110718 3.439 
2 Sample 1132720 3.149 1112680 3.434 
3 Blank - - - - 
4 Placebo - - - - 
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                              chromatogram representing specificity of standard    
                       
chromatogram representing specificity of sample 
RESULT 
Chromatograms explain that retention time for standard, sample and 
commercial product of Levofloxacin and Azithromycin are same. This proves that, 
excipients have no effect on the analytical method. On the other hand, blank peak 
did not overlap drug peak. So the method is highly selective. 
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3. ACCURACY: 
Table 13 : Accuracy data for Levofloxacin 
S.NO Accuracy 
level 
injecton Sample area RT 
 
 
 
1 
 
 
 
50% 
1 568379 3.144 
2 568966 3.135 
3 568795 3.143 
4 568355 3.140 
5 568610 3.140 
6 568330 3.147 
 
 
2 
 
 
100% 
1 1132033 3.137 
2 1130164 3.140 
3 1130359 3.150 
 
 
 
3 
 
 
 
150% 
1 1707811 3.139 
2 1701236 3.150 
3 1708003 3.154 
4 1700653 3.146 
5 1709110 3.149 
6 1702553 3.154 
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Table 14 :  Accuracy (%recovery) results of Levofloxacin 
S.NO Accuracy 
level 
Sample 
name 
Sample 
weight 
µg/ml 
added 
µg/ml 
found 
% 
Recovery 
% 
Mean 
 
 
 
1 
 
 
 
50% 
1 691.50 49.500 49.53 100  
 
 
100 
2 691.50 49.500 49.58 100 
3 691.50 49.500 49.57 100 
4 691.50 49.500 49.53 100 
5 691.50 49.500 49.55 100 
6 691.50 49.500 49.53 100 
 
 
2 
 
 
100% 
1 1383.0 99.000 98.65 100  
100 
2 1383.0 99.000 98.49 99 
3 1383.0 99.000 98.50 99 
 
 
 
3 
 
 
 
150% 
1 2074.50 148.500 148.82 100  
 
100 
2 2074.50 148.500 148.25 100 
3 2074.50 148.500 148.84 100 
4 2074.50 148.500 148.20 100 
5 2074.50 148.500 148.94 100 
6 2074.50 148.500 148.37 100 
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Table : Accuracy data for Azithromycin 
S.NO Accuracy 
level 
Sample 
name 
Sampl area RT 
 
 
 
1 
 
 
 
50% 
1 556537 3.430 
2 556271 3.423 
3 556932 3.429 
4 556794 3.424 
5 556958 3.426 
6 556505 3.432 
 
 
2 
 
 
100% 
1 1115710 3.429 
2 1114936 3.430 
3 1113708 3.439 
 
 
 
3 
 
 
 
150% 
1 1662149 3.432 
2 1663514 3.443 
3 1665465 3.447 
4 1660861 3.439 
5 1669800 3.443 
6 1662124 3.447 
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Table 16: Accuracy (%recovery) results of Azithromycin 
S.NO Accuracy 
level 
Sample 
name 
Sample 
weight 
µg/ml 
added 
µg/ml 
found 
% 
Recovery 
% 
Mean 
 
 
 
1 
 
 
 
50% 
1 691.50 50.000 49.85 100  
 
 
100 
2 691.50 50.000 49.82 100 
3 691.50 50.000 49.88 100 
4 691.50 50.000 49.87 100 
5 691.50 50.000 49.88 100 
6 691.50 50.000 49.84 100 
 
 
2 
 
 
100% 
1 1383.00 100.000 99.93 100  
100 
2 1383.00 100.000 99.86 100 
3 1383.00 100.000 99.75 100 
 
 
 
3 
 
 
 
150% 
1 2074.50 150.000 148.87 99  
 
100 
2 2074.50 150.000 148.99 99 
3 2074.50 150.000 149.17 99 
4 2074.50 150.000 148.76 99 
5 2074.50 150.000 149.56 100 
6 2074.50 150.000 148.87 99 
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Typical chromatogram for Accuracy 50 % 
  
Typical chromatogram for Accuracy 100 % 
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                 Typical chromatogram for Accuracy 150 %            
 
RESULT 
Results of accuracy study are presented in the above table. The measured value was 
obtained by recovery test. Spiked amount of both the drug were compared against 
the recovery amount. 
% Recovery was 100.00% for Levofloxacin and 100.00% for Azithromycin. All the 
results indicate that the method is highly accurate.     
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4.PRECISION: 
Table 17: Precision data for Levofloxacin 
S.no RT Area %Assay 
injection1 3.144 1130289 98 
injection2 3.141 1135307 99 
injection3 3.142 1136018 99 
injection4 3.145 1131067 99 
injection5 3.142 1130362 99 
injection6 3.138 1133569 99 
Mean   99 
Std. Dev.   0.22 
% RSD   0.22 
 
Table 18: Precision data for Azithromycin 
S.no RT Area %Assay 
injection1 3.431 1112555 100 
injection 2 3.429 1116367 100 
injection  3 3.428 1113656 100 
injection  4 3.432 1113585 100 
injection  5 3.430 1114698 100 
injection  6 3.428 1114883 100 
Mean   100 
Std. Dev.   0.12 
%RSD   0.12 
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Chromatogra m for precision injection 1 
 
Chromatogram for precision injection 2 
 
 
Chromatogram for precision injection 3 
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Chromatogram for precision injection 4 
 
 
Chromatogram for precision injection 5 
 
Chromatogram for precision injection 6 
RESULT 
Results of variability were summarized in the above table. % RSD of peak areas was 
calculated for various run. Percentage relative standard deviation (%RSD) was 
found to be less than 2% which proves that method is precise. 
Chapter 7 
Dept of Pharmaceutical Analysis
 LINEARITY: 
s.no 
1. 
2. 
3. 
4. 
5. 
Std.dev 
Slope 
Intercept 
Correlation 
coefficient (r
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Table 19: Linearity data for Levofloxacin
Conc(µg/ml) RT 
50 3.155 
75 3.146 
100 3.136 
125 3.139 
150 3.137 
  
  
  
2) 
  
 
 
  Linearity plot of Levofloxacin 
 
 
 
 
Area 
568388 
852253 
1131849 
1427500 
1700737 
 
 
 
 
0.999 
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Table 20 : Linearity data for Azithromycin
 
Conc(µg/ml) RT 
50 3.443 
75 3.433 
100 3.426 
125 3.431 
150 3.428 
  
  
  
) 
  
 
 
 Linearity plot of Azithromycin 
 
 
 
Area 
556498 
834448 
1113804 
1395652 
1660930 
 
 
 
0.999 
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                Chromatogram representing lineartity 1 
 
Chromatogram representing linearity 2 
 
               Chromatogram representing linearity 3 
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Chromatogram representing linearity 4 
 
Chromatogram representing linearity 5 
RESULT 
A linear relationship between peak areas versus concentrations was observed for 
Levofloxacin and Azithromycin in the range of 50% to 150% of nominal 
concentration. Correlation coefficient was 0.999 for both Levofloxacin and 
Azithromycin which prove that the method is linear in the range of 50% to 150%. 
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6. ROBUSTNESS:  
Table 21 : Robustness data for Levofloxacin   
parameter RT Theoretical plates Asymmetry 
Decreased flow 
rate(0.8ml/min) 
4.178 12562 1.52 
Actual flow 
ate(1.0ml/min) 
3.154 11143 1.49 
Increased flow 
rate(1.2ml/min) 
2.516 10342 1.40 
Decreased 
temperature(200c) 
4.179 12660 1.52 
Actual 
temperature(250c) 
3.154 11143 1.49 
Increased 
temperature(300c) 
4.183 12750 1.52 
                     
Table 22:  Robustness data for Azithromycin 
parameter RT Theoretical plates Asymmetry 
Decreased flow  rate 
(0.8ml/min) 
4.564 14378 
 
1.30 
Actual flow rate 
(1.0ml/min) 
3.439 13998 1.30 
Increased flow rate 
(1.2ml/min) 
2.746 12574 1.32 
Decreased  
temperature(200c) 
4.564 14785 1.28 
Actual temperature(250c) 3.439 13998 1.30 
Increasedtemperature(300c) 4.568 14978 1.30 
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        Chromatogram for decreased flowrate 
 
Chromatogram for increased flowrate 
 
Chromatogram for decreased temperature 
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Chromatogram for increased temperature 
RESULT 
The results of Robustness of the present method had shown that changes made in the 
Flow and Temperature did not produce significant changes in analytical results 
which were presented in the above table. As the changes are not significant we can 
say that the method is Robust. 
 
7. LIMIT OF DETCTION: 
Minimum concentration of standard component in which the peak of the standard 
gets merged with noise called the LOD 
LOD = 3.3* σ/S 
Where; 
σ = standard deviation 
S = slope 
LOD for Levofloxacin = 2.830 
LOD for Azithromycin =2.9412 
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LOD data for Levofloxacin and Azithromycin 
s.no Sample 
name 
RT Area 
1 Levofloxacin 3.146 1411711 
2 Azithromycin 3.433 2061485 
 
 
Chromatrogram for LOD 
8. LIMIT OF QUANTIFICATION: 
 Minimum concentration of standard component in which the peak of the standard 
gets detected and quantification 
LOQ = 10*σ/S 
Where; 
σ = standard deviation 
S = slope 
LOQ for Levofloxacin =9.434 
  LOQ for Azithromycin =9.8039 
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LOQ data for Levofloxacin and Azithromycin 
S.no Sample name RT Area 
1 Levofloxacin 3.142 1380760 
2 Azithromycin 3.430 1866930 
 
 
Chromatogram for LOQ 
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ASSAY:     
 
  Table 23 : Assay data for Levofloxacin and  Azithromycin 
 
 Levofloxacin Azithromycin 
S.No Standard Area Sample area 
Standard 
Area Sample area 
1 1130289 1131289 1112555 1111555 
2 1135307 1133307 1116367 1112367 
3 1136018 1134018 1113656 1110656 
4 1131067 1131067 1113585 1113585 
5 1130362 1129362 1114698 1114698 
Average 113268.6 113172.4 
 
111417.2 
 
 
1112572 
 
Tablet 
average 
weight 
1383.0 1383.0 
Standard 
weight 500 500 
Sample 
weight 1383.0 1383.0 
Label amount 500 500 
std.purity 99.1 99.7 
%Assay 99.31 99.40 
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Fig. no. 46: Chromatogram for assay of sample 1 
 
 
 
    Fig. no.47: Chromatogram for assay of standard 1 
Result: 
 The % assay of the Levofloxacinwas found to be 99.31% and for 
Azithromycinis 99.40%. 
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8. CONCLUSION 
The study is focused to develop and validate HPLC methods for estimation 
of Levofloxacin and Azithromycin in tablet dosage form. 
For routine analytical purpose it is desirable to establish methods capable of 
analyzing huge number of samples in a short time period with good robustness, 
accuracy and precision without any prior separation steps. HPLC method generates 
large amount of quality data, which serve as highly powerful and convenient 
analytical tool. 
The method shows good reproducibility and good recovery. From the 
specificity studies, it was found that the developed methods were specific for 
Levofloxacin and Azithromycin 
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SUMMARY 
SUMMARY OF LEVOFLOXACIN : 
 Summary of validation data for levofloxacin 
S.NO PARAMETER RESULT ACCEPTENCE 
CRITERIA 
1 System suitability 
Theoretical plates 
Asymmetry 
Retention time 
%RSD 
 
14206  
1.35 
3.154 
0.3  
 
Not less than 2500 
Not more than2 
 
Not more than 2% 
2 Specificity 
a) Blank interference 
b) Placebo interference 
 
Specific 
 
Specific 
3 Method precision(%RSD) 0.22 Not more than 
2.0% 
4 Linearity parameter 
Slope 
Intercept 
Correlation coefficient(r2) 
50-150 mcg/ml 
 
 
0.999 
 
 
 
Not less than 0.999 
5 Accuracy 
(Mean % recovery) 
            50% 
           100% 
           150% 
 
 
100% 
100% 
100% 
 
 
 
97.00 – 103.00% 
6 Robustness 
a) Flow rate variation 
b) Temperature variation 
All the system 
suitability 
parameters are 
within the 
limits. 
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SUMMARY OF AZITHROMYCIN : 
Summary of validation data for Azithromycin 
S.NO PAAMETER RESULT ACCEPTENCE 
CRITERIA 
1 System suitability 
Theoretical plates 
Asymmetry 
Retention time 
%RSD 
 
11075 
1.55 
3.436 
0.2 
 
Not less than 2000 
Not more than 2 
 
Not more than 2 
2 Specificity 
c) Blank interference 
d) Placebo interference 
 
 
Specific 
 
 
Specific 
3 Method precision(%RSD) 0.12 Not more than 2.0% 
4 Linearity parameter 
Slope 
Intercept 
Correlation coefficient(r2) 
50-150 
mcg/ml 
 
 
0.999 
 
 
 
Not less than 0.999 
5 Accuracy 
(Mean % recovery) 
50% 
100% 
150% 
 
 
100 
100 
100 
 
 
 
97 - 103% 
6 Robustness 
c) Flow rate variation 
d) Temperature 
variation 
All the system 
suitability 
parameters are 
within the 
limits. 
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